Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 513, 63-74
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 33 references indexed in Scilit:
- Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responsesProceedings of the National Academy of Sciences, 2014
- Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1Cancer Research, 2014
- MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasisTumor Biology, 2013
- Macrophage Regulation of Tumor Responses to Anticancer TherapiesCancer Cell, 2013
- Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factorCell Research, 2012
- Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and ProliferationCancer Research, 2010
- Simultaneous determination of five main active bufadienolides of Chan Su in rat plasma by liquid chromatography tandem mass spectrometryJournal of Chromatography B, 2007
- High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogeneCancer Cell, 2004
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 2004
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004